Burnett, A. K., Das Gupta, E., Knapper, S., Khwaja, A., Sweeney, M., Kjeldsen, L., Hawkins, T., Betteridge, S. E., Cahalin, P., Clark, R. E., Hills, R. K. and Russell, N. H. (2018) “Addition of the mammalian target of rapamycin inhibitor, everolimus, to consolidation therapy in acute myeloid leukemia: experience from the UK NCRI AML17 trial”, Haematologica. Pavia, Italy, 103(10), pp. 1654-1661. doi: 10.3324/haematol.2018.189514.